Compounds > 8-hydroxy-2-(di-n-propylamino)tetralin
Page last updated: 2024-10-21

8-hydroxy-2-(di-n-propylamino)tetralin and Cortical Lewy Body Disease

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with Cortical Lewy Body Disease in 1 studies

8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sharp, SI1
Ballard, CG1
Ziabreva, I1
Piggott, MA1
Perry, RH1
Perry, EK1
Aarsland, D1
Ehrt, U1
Larsen, JP1
Francis, PT1

Other Studies

1 other study available for 8-hydroxy-2-(di-n-propylamino)tetralin and Cortical Lewy Body Disease

ArticleYear
Cortical serotonin 1A receptor levels are associated with depression in patients with dementia with Lewy bodies and Parkinson's disease dementia.
    Dementia and geriatric cognitive disorders, 2008, Volume: 26, Issue:4

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Aged; Aged, 80 and over; Antidepressive Agents; Antiparkinso

2008